Topics Comments
 < Previous page    Next page > 
Cheung Kong VODone Limited Shenzhen International Holdings Limited Jiangxi Copper Company Limited REXLot Holdings Limited China Overseas Land & Investment Limited Chong Hing Bank Limited Agricultural Bank of China Limited Chow Tai Fook Jewellery Group Limited Capital VC Limited iShares A50 Standard Chartered Bank of Communications Bank of China China LotSynergy Holdings Limited agribank Agri Airlines Appl AUD Auto A Shares Brokers CAD fertilizer producers China Lottery Supermarket China Banks Communication Consumer China Econ Electricity China Finance China IT Petro Real Est China Resource Steel coal Commodity Beauty Drugs Enviro EURO Lang Simon Ting WongSir Andy Xie Expo Gambling Garment gas GBD Gold Gold Jew Gold mine Harbour Highways HK Apparel REITs Rentals HK Banks ETF HK Housing Market Real Est HK HK Stock iBond Infra Insure IPO jewel Mach Build Mat New Energy NZD Oil Paper Rare Earths Real Estate Market Food RMB Rising RMB RMB Bonds Shipbuilding Shipping Sports Stock Trend Taiwan Dollar (TWD) Textile Top 500 USD US Econ Util Water Yang Liu's 10 Stocks YEN Diary media Central Bank Monetary Policy Education Construction Emerging markets Nuclear power BillGross Cement HK retail logistics Swiss franc Social Security Fund Law Ka-Chung capital flow Financial and political policy Railway film Korean Won Roubini Faber Mobius
Topics Last reply time Nickname Content
Sinopharm Group Co. Ltd. 2019-12-13T14:49 財經茄呢啡 醫藥股回升，石藥集團現報１７．２４元，升１．４％；康哲醫藥現報１１．７２元，升４％；國藥控股現報２６．４５元，升０．７６％。
Sinopharm Group Co. Ltd. 2019-12-13T14:49 財經茄呢啡 依據《中華人民共和國藥品管理法》及其實施條例規定，按照《藥品經營質量管理規范認證管理辦法》和《江蘇省藥品經營質量管理認證工作程序》組織認證檢查，國藥控股江陰華宏醫藥有限公司等３家企業符合《藥品經營質量管理規范》，現予公示。
Sinopharm Group Co. Ltd. 2019-12-06T14:56 財經茄呢啡 醫藥股偏強，國藥控股收報２８．５０元，升２．３３％；石藥集團收報２１．４０元，升４．３％，是表現最好藍籌；康哲醫藥收報１２．０２元，升７．５％。
Sinopharm Group Co. Ltd. 2019-12-06T14:56 財經茄呢啡 醫藥股回升，中國生物制藥半日收報１１．５元，升３．２３％；石藥集團半日收報２１．４５元，升４．３８％；國藥控股半日收報２６．８５元，升０．９４％。
Sinopharm Group Co. Ltd. 2019-11-22T15:04 財經茄呢啡 醫藥股回升，中國生物制藥半日收報１１．５元，升３．２３％；石藥集團半日收報２１．４５元，升４．３８％；國藥控股半日收報２６．８５元，升０．９４％。
Sinopharm Group Co. Ltd. 2019-11-15T14:48 財經茄呢啡 不同於恆瑞醫藥的是，復星醫藥似乎將更多心思花在了收購整合子公司上。企查查數據顯示，截至１１月１日復星醫藥對外投資機構已達３１家，其中不乏有國藥控股、重慶藥友、漢霖生技等藥企的身影。
Sinopharm Group Co. Ltd. 2019-11-15T14:48 財經茄呢啡 醫藥股捱沽，石藥集團半日收報２０．６０元，下滑２．１％；國藥控股半日收報２７．５０元，升０．１８％；康哲醫藥半日收報１２元，下滑０．４９％；中國生物制藥半日收報１１．２２元，下滑２％。
Sinopharm Group Co. Ltd. 2019-11-15T14:48 財經茄呢啡 植耀輝提醒，藥品降價也是大趨勢，所以建議投資者留意醫藥股往後業績，若沒有因降價影響其利潤，就可考慮買進。譚朗蔚另指，中國政府提倡藥品當家，所以主力做藥品分銷的國藥控股利潤增加有限。
Sinopharm Group Co. Ltd. 2019-11-08T14:52 財經茄呢啡 國藥控股發布２０１９年第三季度歸母淨盈利４．７億元人民幣，同比提升３４．９％。營收同比提升３６．７％至２９９．３億元人民幣，營業盈利同比提升３９．３％至１１．０億元人民幣。
Sinopharm Group Co. Ltd. 2019-11-08T14:52 財經茄呢啡 醫藥股有買盤，石藥集團半日收報２１．１５元，升３．１７％，是表現最佳藍籌；國藥控股半日收報２８．４０元，升１．９７％；中國生物制藥半日收報１１．９元，升０．５％。
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.